ID

15410

Beschreibung

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02396043

Link

https://clinicaltrials.gov/show/NCT02396043

Stichworte

  1. 30.05.16 30.05.16 -
Hochgeladen am

30. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lymphoma, Lymphoblastic NCT02396043

Eligibility Lymphoma, Lymphoblastic NCT02396043

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosedt-lbl
Beschreibung

Lymphoblastic T-cell lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2853920
age:18-65years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ann arbor stage ieto stage ive
Beschreibung

Ann Arbor lymphoma staging system

Datentyp

boolean

Alias
UMLS CUI [1]
C0432516
at lease one measurable lesion
Beschreibung

Measurable lesion

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
receive no chemotherapy or radiotherapy before
Beschreibung

Chemotherapy Regimen Firstly | Therapeutic radiology procedure Firstly

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1279901
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C1279901
adequate renal function (eg, serum creatinine≤1.5 mg/dl and creatinine clearance ≥50 ml minute), and hepatic function (e.g, total bilirubin≤ 2 times the upper limit of normal and aspartate and alanine transaminase levels ≤ 3 times the upper limit of normal)
Beschreibung

Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Liver function | Bilirubin, total measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0373595
UMLS CUI [4]
C0232741
UMLS CUI [5]
C0201913
UMLS CUI [6]
C0201899
UMLS CUI [7]
C0201836
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
mismatch the inclusion criteria
Beschreibung

Mismatch Inclusion criteria

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1881865
UMLS CUI [1,2]
C1512693
systematic central nervous system involvement, previous or concomitant malignancies and any coexisting medical problems that could cause poor compliance with the study protocol.
Beschreibung

Central Nervous System Involvement systematic | Malignant Neoplasms | Comorbidity Compliance behavior Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3714787
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C0220922
UMLS CUI [2]
C0006826
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C1321605
UMLS CUI [3,3]
C0439801

Ähnliche Modelle

Eligibility Lymphoma, Lymphoblastic NCT02396043

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoblastic T-cell lymphoma
Item
newly diagnosedt-lbl
boolean
C2853920 (UMLS CUI [1])
Age
Item
age:18-65years
boolean
C0001779 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage ieto stage ive
boolean
C0432516 (UMLS CUI [1])
Measurable lesion
Item
at lease one measurable lesion
boolean
C1513041 (UMLS CUI [1])
Chemotherapy Regimen Firstly | Therapeutic radiology procedure Firstly
Item
receive no chemotherapy or radiotherapy before
boolean
C0392920 (UMLS CUI [1,1])
C1279901 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1279901 (UMLS CUI [2,2])
Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Liver function | Bilirubin, total measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
adequate renal function (eg, serum creatinine≤1.5 mg/dl and creatinine clearance ≥50 ml minute), and hepatic function (e.g, total bilirubin≤ 2 times the upper limit of normal and aspartate and alanine transaminase levels ≤ 3 times the upper limit of normal)
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
C0201913 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
Mismatch Inclusion criteria
Item
mismatch the inclusion criteria
boolean
C1881865 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
Central Nervous System Involvement systematic | Malignant Neoplasms | Comorbidity Compliance behavior Limited
Item
systematic central nervous system involvement, previous or concomitant malignancies and any coexisting medical problems that could cause poor compliance with the study protocol.
boolean
C3714787 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0220922 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2])
C0009488 (UMLS CUI [3,1])
C1321605 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video